-
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
(PAR-22-078)
National Institutes of Health
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): June 24, 2022
-
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
(RFA-HL-23-010)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
(RFA-HL-23-011)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
(RFA-HL-23-012)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
(RFA-HL-23-013)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Multiple dates, see announcement.
-
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
(RFA-HL-23-014)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): December 20, 2024
-
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
(RFA-MH-22-115)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): May 7, 2023
-
NIMH Instrumentation Program (S10 Clinical Trial Not Allowed)
(RFA-MH-22-155)
National Institute of Mental Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
(RFA-NR-22-001)
National Institute of Nursing Research
National Institute on Drug Abuse
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): April 7, 2022
-
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Required)
(RFA-NR-22-002)
National Institute of Nursing Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): April 7, 2022
-
Advancing Integrated Models (AIM) of Care to Improve Maternal Health Outcomes among Women Who Experience Persistent Disparities (R21 Clinical Trial Optional)
(RFA-NR-22-003)
National Institute of Nursing Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): April 7, 2022